抗生物質耐性市場：疾患別、病原体別、薬剤クラス別、作用機序別、流通チャネル別、世界予測、2023-2032年

抗生物質耐性市場は2023年から2032年にかけてCAGR 5.3％で成長する見通しです。

抗生物質の誤用が引き金となった薬剤耐性菌の発生は、代替治療オプションへの需要を高め、業界の拡大を後押ししています。

さらに、感染症にかかりやすくなった世界人口の高齢化が、新規抗生物質の必要性を高めています。ヘルスケア関連感染の調査と多剤耐性病原体の出現も、抗生物質耐性に対抗するための新規抗菌薬の研究開発への投資を促進しています。

政府のイニシアチブ、規制上の優遇措置、抗生物質耐性の脅威に対する意識の高まりは、市場拡大にさらに貢献すると思われます。2022年11月、国連のFAO、UNEP、世界動物衛生機関、WHOは、世界人口に対する抗菌薬耐性の深刻な影響に対処するため、「抗菌薬耐性マルチステークホルダー・パートナーシップ・プラットフォーム」と呼ばれる新たなイニシアチブを発表しました。革新的な解決策が急務であることから、抗菌薬耐性産業は今後数年で大きく拡大すると思われます。

市場は、疾患、病原体、薬剤クラス別、作用機序、流通チャネル、地域に基づいて分別されます。

疾患に基づくと、血流感染セグメントは2023年から2032年にかけて5％のCAGRを示します。敗血症と血流感染症の有病率の増加、ヘルスケア関連症例の増加、クリティカルケア環境における抗生物質耐性病原体の課題の増加が、このセグメントの成長を促進します。

緑膿菌病原体セグメントは、2032年までのCAGRが6.5%になると予測されます。これは、この病原体が複数の抗生物質に対して広く耐性を持つようになり、代替治療への需要が高まっていることなどが要因です。ヘルスケア環境における緑膿菌感染の増加も、このセグメントの成長を促進すると思われます。

セファロスポリン薬剤クラス別セグメントは、2023年から2032年にかけてCAGR 6.1%を示すと予想されます。これは、セファロスポリン耐性菌の蔓延が加速していることが要因であり、新規かつ効果的な治療法の開発が必要となります。ヘルスケア関連感染の増加や革新的な抗菌薬への需要も、このセグメントの成長を増大させると思われます。

地域別では、アジア太平洋地域の抗生物質耐性産業は、2032年までのCAGRが5.8%になると予想され、同地域におけるヘルスケアへのアクセスの増加、人口密度、抗菌薬の誤用などの要因によって牽引されます。同地域が抗生物質耐性の課題に取り組んでいることから、意識の高まり、政府の取り組み、経済発展が業界の拡大をさらに促進すると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 抗生物質耐性市場の洞察

• 業界情勢
• 業界への影響要因
  • 成長促進要因
    • 抗生物質耐性感染症の増加
    • 新しい抗生物質治療に対するニーズの高まり
    • 新規抗生物質の研究開発への投資の増加
    • 世界の公衆衛生への関心と意識の高まり
  • 業界の潜在的リスク＆課題
    • 治療薬の高コスト
    • 複雑な規制と開発プロセス
• 成長可能性分析
• COVID-19の影響分析
• 規制状況
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 競合ポジショニング・マトリックス
• 戦略ダッシュボード

第5章 抗生物質耐性の市場推計・予測：疾患別

• 主要動向：疾患別
• 合併症性尿路感染症
• 合併症性腹腔内感染症
• 血流感染症
• 急性細菌性皮膚・皮膚構造感染症
• 市中肺炎
• クロストリジウム・ディフィシル感染症
• 院内細菌性肺炎

第6章 抗生物質耐性の市場推計・予測：病原体別

• 主要動向：病原体別
• 大腸菌
• 肺炎桿菌
• 緑膿菌
• 黄色ブドウ球菌
• バウマンニ
• 肺炎桿菌
• インフルエンザ菌
• C. difficile
• フェシウム

第7章 抗生物質耐性の市場推計・予測：薬剤クラス別

• 主要動向：薬剤クラス別
• オキサゾリジノン
• セファロスポリン
• リポグリコペプチド
• 併用療法
• テトラサイクリン
• その他の薬剤クラス別

第8章 抗生物質耐性の市場推計・予測：作用機序別

• 主要動向：作用機序別
• 細胞壁合成阻害剤
• タンパク質合成阻害剤
• DNA合成阻害剤
• RNA合成阻害剤
• その他の作用機序

第9章 抗生物質耐性の市場推計・予測：流通チャネル別

• 主要動向：流通チャネル別
• 病院薬局
• 小売薬局
• オンライン薬局

第10章 抗生物質耐性の市場推計・予測：地域別

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • スイス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第11章 企業プロファイル

• ACHAOGEN, INC.
• Basilea Pharmaceutica Ltd.
• MELINTA THERAPEUTICS
• Tetraphase Pharmaceuticals, Inc.
• Theravance Biopharma
• WOCKHARDT
• Entasis therapeutics
• Paratek Pharmaceuticals, Inc.
• Seres Therapeutics
• AbbVie, Inc.
• Merck & Co. Inc.
• Pfizer Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by disease (2022)
• TABLE 3 Market revenue, by pathogen (2022)
• TABLE 4 Market revenue, by drug class (2022)
• TABLE 5 Market revenue, by mechanism of action (2022)
• TABLE 6 Market revenue, by distribution channel (2022)
• TABLE 7 Market share, by region (2022)
• TABLE 8 Global antibiotic resistance market size, by region, 2018 - 2022 (USD Million)
• TABLE 9 Global antibiotic resistance market size, by region, 2023 - 2032 (USD Million)
• TABLE 10 Global antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 11 Global antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 12 Global antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 13 Global antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 14 Global antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 15 Global antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 16 Global antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 17 Global antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 18 Global antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 19 Global antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 20 Industry impact forces
• TABLE 21 Competitive benchmarking of major market players
• TABLE 22 Competitive positioning matrix: Classification criteria
• TABLE 23 Strategic outlook matrix: Classification criteria
• TABLE 24 Complicated urinary tract infections market size, by region, 2018 - 2022 (USD Million)
• TABLE 25 Complicated urinary tract infections market size, by region, 2023 - 2032 (USD Million)
• TABLE 26 Complicated intra-abdominal infections market size, by region, 2018 - 2022 (USD Million)
• TABLE 27 Complicated intra-abdominal infections market size, by region, 2023 - 2032 (USD Million)
• TABLE 28 Bloodstream infection market size, by region, 2018 - 2022 (USD Million)
• TABLE 29 Bloodstream infection market size, by region, 2023 - 2032 (USD Million)
• TABLE 30 Acute bacterial skin and skin-structure infection market size, by region, 2018 - 2022 (USD Million)
• TABLE 31 Acute bacterial skin and skin-structure infection market size, by region, 2023 - 2032 (USD Million)
• TABLE 32 Community-acquired bacterial pneumonia market size, by region, 2018 - 2022 (USD Million)
• TABLE 33 Community-acquired bacterial pneumonia market size, by region, 2023 - 2032 (USD Million)
• TABLE 34 Clostridium difficile infections market size, by region, 2018 - 2022 (USD Million)
• TABLE 35 Clostridium difficile infections market size, by region, 2023 - 2032 (USD Million)
• TABLE 36 Hospital-acquired bacterial pneumonia market size, by region, 2018 - 2022 (USD Million)
• TABLE 37 Hospital-acquired bacterial pneumonia market size, by region, 2023 - 2032 (USD Million)
• TABLE 38 E. coli market size, by region, 2018 - 2022 (USD Million)
• TABLE 39 E. coli market size, by region, 2023 - 2032 (USD Million)
• TABLE 40 K. pneumoniae market size, by region, 2018 - 2022 (USD Million)
• TABLE 41 K. pneumoniae market size, by region, 2023 - 2032 (USD Million)
• TABLE 42 P. aeruginosa market size, by region, 2018 - 2022 (USD Million)
• TABLE 43 P. aeruginosa market size, by region, 2023 - 2032 (USD Million)
• TABLE 44 S. aureus market size, by region, 2018 - 2022 (USD Million)
• TABLE 45 S. aureus market size, by region, 2023 - 2032 (USD Million)
• TABLE 46 Baumannii market size, by region, 2018 - 2022 (USD Million)
• TABLE 47 Baumannii market size, by region, 2023 - 2032 (USD Million)
• TABLE 48 S. pneumoniae market size, by region, 2018 - 2022 (USD Million)
• TABLE 49 S. pneumoniae market size, by region, 2023 - 2032 (USD Million)
• TABLE 50 H. influenzae market size, by region, 2018 - 2022 (USD Million)
• TABLE 51 H. influenzae market size, by region, 2023 - 2032 (USD Million)
• TABLE 52 C. difficile market size, by region, 2018 - 2022 (USD Million)
• TABLE 53 C. difficile market size, by region, 2023 - 2032 (USD Million)
• TABLE 54 E. faecium market size, by region, 2018 - 2022 (USD Million)
• TABLE 55 E. faecium market size, by region, 2023 - 2032 (USD Million)
• TABLE 56 Oxazolidinones market size, by region, 2018 - 2022 (USD Million)
• TABLE 57 Oxazolidinones market size, by region, 2023 - 2032 (USD Million)
• TABLE 58 Cephalosporin market size, by region, 2018 - 2022 (USD Million)
• TABLE 59 Cephalosporin market size, by region, 2023 - 2032 (USD Million)
• TABLE 60 Lipoglycopeptides market size, by region, 2018 - 2022 (USD Million)
• TABLE 61 Lipoglycopeptides market size, by region, 2023 - 2032 (USD Million)
• TABLE 62 Combination therapies market size, by region, 2018 - 2022 (USD Million)
• TABLE 63 Combination therapies market size, by region, 2023 - 2032 (USD Million)
• TABLE 64 Tetracyclines market size, by region, 2018 - 2022 (USD Million)
• TABLE 65 Tetracyclines market size, by region, 2023 - 2032 (USD Million)
• TABLE 66 Other drug classes market size, by region, 2018 - 2022 (USD Million)
• TABLE 67 Other drug classes market size, by region, 2023 - 2032 (USD Million)
• TABLE 68 Cell wall synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
• TABLE 69 Cell wall synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
• TABLE 70 Protein synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
• TABLE 71 Protein synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
• TABLE 72 DNA synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
• TABLE 73 DNA synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
• TABLE 74 RNA synthesis inhibitors market size, by region, 2018 - 2022 (USD Million)
• TABLE 75 RNA synthesis inhibitors market size, by region, 2023 - 2032 (USD Million)
• TABLE 76 Other mechanism of actions market size, by region, 2018 - 2022 (USD Million)
• TABLE 77 Other mechanism of actions market size, by region, 2023 - 2032 (USD Million)
• TABLE 78 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 79 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 80 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 81 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 82 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 83 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 84 North America antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
• TABLE 85 North America antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
• TABLE 86 North America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 87 North America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 88 North America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 89 North America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 90 North America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 91 North America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 92 North America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 93 North America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 94 North America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 95 North America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 96 U.S. antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 97 U.S. antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 98 U.S. antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 99 U.S. antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 100 U.S. antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 101 U.S. antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 102 U.S. antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 103 U.S. antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 104 U.S. antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 105 U.S. antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 106 Canada antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 107 Canada antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 108 Canada antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 109 Canada antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 110 Canada antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 111 Canada antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 112 Canada antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 113 Canada antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 114 Canada antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 115 Canada antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 116 Europe antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
• TABLE 117 Europe antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
• TABLE 118 Europe antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 119 Europe antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 120 Europe antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 121 Europe antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 122 Europe antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 123 Europe antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 124 Europe antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 125 Europe antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 126 Europe antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 127 Europe antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 128 Germany antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 129 Germany antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 130 Germany antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 131 Germany antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 132 Germany antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 133 Germany antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 134 Germany antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 135 Germany antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 136 Germany antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 137 Germany antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 138 UK antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 139 UK antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 140 UK antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 141 UK antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 142 UK antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 143 UK antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 144 UK antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 145 UK antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 146 UK antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 147 UK antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 148 France antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 149 France antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 150 France antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 151 France antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 152 France antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 153 France antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 154 France antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 155 France antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 156 France antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 157 France antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 158 Spain antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 159 Spain antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 160 Spain antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 161 Spain antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 162 Spain antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 163 Spain antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 164 Spain antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 165 Spain antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 166 Spain antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 167 Spain antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 168 Italy antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 169 Italy antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 170 Italy antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 171 Italy antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 172 Italy antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 173 Italy antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 174 Italy antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 175 Italy antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 176 Italy antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 177 Italy antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 178 Switzerland antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 179 Switzerland antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 180 Switzerland antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 181 Switzerland antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 182 Switzerland antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 183 Switzerland antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 184 Switzerland antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 185 Switzerland antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 186 Switzerland antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 187 Switzerland antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 188 Rest of Europe antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 189 Rest of Europe antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 190 Rest of Europe antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 191 Rest of Europe antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 192 Rest of Europe antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 193 Rest of Europe antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 194 Rest of Europe antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 195 Rest of Europe antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 196 Rest of Europe antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 197 Rest of Europe antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 198 Asia Pacific antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
• TABLE 199 Asia Pacific antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
• TABLE 200 Asia Pacific antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 201 Asia Pacific antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 202 Asia Pacific antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 203 Asia Pacific antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 204 Asia Pacific antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 205 Asia Pacific antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 206 Asia Pacific antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 207 Asia Pacific antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 208 Asia Pacific antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 209 Asia Pacific antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 210 China antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 211 China antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 212 China antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 213 China antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 214 China antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 215 China antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 216 China antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 217 China antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 218 China antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 219 China antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 220 Japan antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 221 Japan antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 222 Japan antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 223 Japan antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 224 Japan antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 225 Japan antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 226 Japan antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 227 Japan antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 228 Japan antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 229 Japan antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 230 India antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 231 India antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 232 India antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 233 India antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 234 India antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 235 India antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 236 India antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 237 India antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 238 India antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 239 India antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 240 Australia antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 241 Australia antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 242 Australia antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 243 Australia antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 244 Australia antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 245 Australia antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 246 Australia antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 247 Australia antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 248 Australia antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 249 Australia antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 250 South Korea antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 251 South Korea antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 252 South Korea antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 253 South Korea antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 254 South Korea antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 255 South Korea antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 256 South Korea antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 257 South Korea antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 258 South Korea antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 259 South Korea antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 260 Rest of Asia Pacific antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 261 Rest of Asia Pacific antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 262 Rest of Asia Pacific antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 263 Rest of Asia Pacific antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 264 Rest of Asia Pacific antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 265 Rest of Asia Pacific antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 266 Rest of Asia Pacific antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 267 Rest of Asia Pacific antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 268 Rest of Asia Pacific antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 269 Rest of Asia Pacific antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 270 Latin America antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
• TABLE 271 Latin America antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
• TABLE 272 Latin America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 273 Latin America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 274 Latin America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 275 Latin America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 276 Latin America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 277 Latin America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 278 Latin America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 279 Latin America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 280 Latin America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 281 Latin America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 282 Brazil antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 283 Brazil antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 284 Brazil antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 285 Brazil antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 286 Brazil antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 287 Brazil antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 288 Brazil antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 289 Brazil antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 290 Brazil antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 291 Brazil antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 292 Mexico antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 293 Mexico antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 294 Mexico antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 295 Mexico antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 296 Mexico antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 297 Mexico antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 298 Mexico antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 299 Mexico antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 300 Mexico antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 301 Mexico antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 302 Rest of Latin America antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 303 Rest of Latin America antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 304 Rest of Latin America antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 305 Rest of Latin America antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 306 Rest of Latin America antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 307 Rest of Latin America antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 308 Rest of Latin America antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 309 Rest of Latin America antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 310 Rest of Latin America antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 311 Rest of Latin America antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 312 Middle East & Africa antibiotic resistance market size, by country, 2018 - 2022 (USD Million)
• TABLE 313 Middle East & Africa antibiotic resistance market size, by country, 2023 - 2032 (USD Million)
• TABLE 314 Middle East & Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 315 Middle East & Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 316 Middle East & Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 317 Middle East & Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 318 Middle East & Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 319 Middle East & Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 320 Middle East & Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 321 Middle East & Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 322 Middle East & Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 323 Middle East & Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 324 South Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 325 South Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 326 South Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 327 South Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 328 South Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 329 South Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 330 South Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 331 South Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 332 South Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 333 South Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 334 Saudi Arabia antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 335 Saudi Arabia antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 336 Saudi Arabia antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 337 Saudi Arabia antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 338 Saudi Arabia antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 339 Saudi Arabia antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 340 Saudi Arabia antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 341 Saudi Arabia antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 342 Saudi Arabia antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 343 Saudi Arabia antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 344 Rest of Middle East & Africa antibiotic resistance market size, by disease, 2018 - 2022 (USD Million)
• TABLE 345 Rest of Middle East & Africa antibiotic resistance market size, by disease, 2023 - 2032 (USD Million)
• TABLE 346 Rest of Middle East & Africa antibiotic resistance market size, by pathogen, 2018 - 2022 (USD Million)
• TABLE 347 Rest of Middle East & Africa antibiotic resistance market size, by pathogen, 2023 - 2032 (USD Million)
• TABLE 348 Rest of Middle East & Africa antibiotic resistance market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 349 Rest of Middle East & Africa antibiotic resistance market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 350 Rest of Middle East & Africa antibiotic resistance market size, by mechanism of action, 2018 - 2022 (USD Million)
• TABLE 351 Rest of Middle East & Africa antibiotic resistance market size, by mechanism of action, 2023 - 2032 (USD Million)
• TABLE 352 Rest of Middle East & Africa antibiotic resistance market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 353 Rest of Middle East & Africa antibiotic resistance market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Top-down approach
• FIG. 3 Market estimation and forecast methodology
• FIG. 4 Market forecasting methodology
• FIG. 5 Breakdown of primary participants
• FIG. 6 Antibiotic resistance industry 360 degree synopsis, 2018 - 2032
• FIG. 7 Growth potential analysis, by disease
• FIG. 8 Growth potential analysis, by pathogen
• FIG. 9 Growth potential analysis, by drug class
• FIG. 10 Growth potential analysis, by mechanism of action
• FIG. 11 Growth potential analysis, by distribution channel
• FIG. 12 Porter's analysis
• FIG. 13 PESTEL analysis
• FIG. 14 Company matrix analysis, 2022
• FIG. 15 Competitive positioning matrix, 2022
• FIG. 16 Strategic dashboard, 2022

The antibiotic resistance market will grow with 5.3% CAGR from 2023 to 2032. The development of drug-resistant bacteria triggered by misuse of antibiotic medications is increasing the demand for alternative treatment options, propelling industry expansion.

Additionally, the aging global population, with a higher susceptibility to infections, is driving the need for novel antibiotics. Rising healthcare-associated infections and the emergence of multi-drug-resistant pathogens have also fueled investments in research and development of new antimicrobial agents to combat antibiotic resistance.

Government initiatives, regulatory incentives, and increased awareness about the threat of antibiotic resistance will further contribute to market expansion. In November 2022, the UN's FAO, UNEP, the World Organization for Animal Health, and the WHO announced a new initiative called the Antimicrobial Resistance Multi-Stakeholder Partnership Platform to address the escalating implications of antimicrobial resistance on the global population. Given the pressing need for innovative solutions, the antibiotic resistance industry will expand significantly in the coming years.

The market is segregated based on disease, pathogen, drug class, mechanism of action, distribution channel, and region.

Based on disease, the bloodstream infection segment will exhibit a 5% CAGR from 2023 to 2032. The increasing prevalence of sepsis and bloodstream infections, rising healthcare-associated cases, and the growing challenge of antibiotic-resistant pathogens in critical care settings will drive growth in the segment.

The P. aeruginosa pathogen segment will reflect a 6.5% CAGR through 2032, driven by factors such as the pathogen's widespread resistance to multiple antibiotics, which is driving the demand for alternative treatments. The rising incidences of P. aeruginosa infections in healthcare settings will also foster growth in the segment.

The cephalosporin drug class segment will exhibit 6.1% CAGR between 2023 and 2032, driven by the escalating prevalence of cephalosporin-resistant bacterial strains, which will necessitate the development of new and effective treatments. The rising burden of healthcare-associated infections and demand for innovative antimicrobial agents will also augment growth in the segment.

Regionally, the Asia Pacific antibiotic resistance industry will witness a 5.8% CAGR through 2032, driven by factors such as increasing healthcare access, population density, and antimicrobial misuse in the region. Rising awareness, government initiatives, and economic development will further drive industry expansion as the region addresses antibiotic resistance challenges.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Antibiotic resistance industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Disease trends
  • 2.1.4 Pathogen trends
  • 2.1.5 Drug class trends
  • 2.1.6 Mechanism of action trends
  • 2.1.7 Distribution channel trends

Chapter 3 Antibiotic Resistance Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of antibiotic resistant infections
    • 3.2.1.2 Growing need for new antibiotic therapies
    • 3.2.1.3 Increasing investment for research and development of novel antibiotics
    • 3.2.1.4 Increasing global public health concern and awareness
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of therapeutics
    • 3.2.2.2 Complex regulatory and development process
• 3.3 Growth potential analysis
  • 3.3.1 By disease
  • 3.3.2 By pathogen
  • 3.3.3 By drug class
  • 3.3.4 By mechanism of action
  • 3.3.5 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Antibiotic Resistance Market Estimates and Forecast, By Disease (USD Million)

• 5.1 Key trends, by disease
• 5.2 Complicated urinary tract infections
• 5.3 Complicated intra-abdominal infections
• 5.4 Bloodstream infection
• 5.5 Acute bacterial skin and skin-structure infection
• 5.6 Community-acquired bacterial pneumonia
• 5.7 Clostridium difficile infections
• 5.8 Hospital-acquired bacterial pneumonia

Chapter 6 Antibiotic Resistance Market Estimates and Forecast, By Pathogen (USD Million)

• 6.1 Key trends, by pathogen
• 6.2 E. coli
• 6.3 K. pneumoniae
• 6.4 P. aeruginosa
• 6.5 S. aureus
• 6.6 Baumannii
• 6.7 S. pneumoniae
• 6.8 H. influenzae
• 6.9 C. difficile
• 6.10 E. faecium

Chapter 7 Antibiotic Resistance Market Estimates and Forecast, By Drug Class (USD Million)

• 7.1 Key trends, by drug class
• 7.2 Oxazolidinones
• 7.3 Cephalosporin
• 7.4 Lipoglycopeptides
• 7.5 Combination therapies
• 7.6 Tetracyclines
• 7.7 Other drug classes

Chapter 8 Antibiotic Resistance Market Estimates and Forecast, By Mechanism of Action (USD Million)

• 8.1 Key trends, by mechanism of action
• 8.2 Cell wall synthesis inhibitors
• 8.3 Protein synthesis inhibitors
• 8.4 DNA synthesis inhibitors
• 8.5 RNA synthesis inhibitors
• 8.6 Other mechanism of actions

Chapter 9 Antibiotic Resistance Market Estimates and Forecast, By Distribution Channel (USD Million)

• 9.1 Key trends, by distribution channel
• 9.2 Hospital pharmacies
• 9.3 Retail pharmacies
• 9.4 Online pharmacies

Chapter 10 Antibiotic Resistance Market Estimates and Forecast, By Region (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Switzerland
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 ACHAOGEN, INC.
• 11.2 Basilea Pharmaceutica Ltd.
• 11.3 MELINTA THERAPEUTICS
• 11.4 Tetraphase Pharmaceuticals, Inc.
• 11.5 Theravance Biopharma
• 11.6 WOCKHARDT
• 11.7 Entasis therapeutics
• 11.8 Paratek Pharmaceuticals, Inc.
• 11.9 Seres Therapeutics
• 11.10 AbbVie, Inc.
• 11.11 Merck & Co. Inc.
• 11.12 Pfizer Inc.